Conference Coverage

Dr. Eve Espey: Some good news in her 2019 contraceptive update


 

EXPERT ANALYSIS FROM ACOG 2019

Additional future directions

One technology in development is a longer-acting injectable, such as a 6- or 9-month Depot-type shot.

Biodegradable implants also are in development. “What a cool idea – it just disappears in your arm, no need to remove it,” Dr. Espey said, adding that nonsurgical permanent sterilization is another possible advance, which would be “a holy grail.”

As for male contraception?

“I’ve been saying for about 25 years that in 5 years we’ll have a male contraceptive, so I’m not going to say it anymore with any kind of time frame, but it’s possible,” she said.

Dr. Espey reported having no financial disclosures.

Pages

Recommended Reading

Concerns over discretion, efficacy lead teen females to use emergency contraception
MDedge Pediatrics
Levonorgestrel implant right after delivery does not affect breastfeeding, infant growth
MDedge Pediatrics
Courts block Trump from eroding contraceptive mandate
MDedge Pediatrics
Delayed first contraception use raises unwanted pregnancy risk
MDedge Pediatrics
Supreme Court halts Louisiana abortion law from taking effect
MDedge Pediatrics
Courts temporarily block Title X changes
MDedge Pediatrics
Addressing the sexual and reproductive health needs of trans and gender nonconforming patients
MDedge Pediatrics
Postpartum LARC uptake increased with separate payment
MDedge Pediatrics
Judge bars contraceptive mandate from being enforced
MDedge Pediatrics
Ovarian reserve markers fall on isotretinoin, but rebound after stopping treatment
MDedge Pediatrics